SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891618-03-001533
Filing Date
2003-03-28
Accepted
2003-03-28 17:26:15
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR ENDED 12/31/2002 f88773e10vk.htm 10-K 889326
3 EXHIBIT 3.1.1 f88773exv3w1w1.txt EX-3.1.1 3995
4 EXHIBIT 10.17.1 f88773exv10w17w1.txt EX-10.17.1 12555
5 EXHIBIT 10.35 f88773exv10w35.txt EX-10.35 31319
6 EXHIBIT 21.1 f88773exv21w1.txt EX-21.1 196
7 EXHIBIT 23.1 f88773exv23w1.txt EX-23.1 838
8 EXHIBIT 99.1 f88773exv99w1.txt EX-99.1 2367
  Complete submission text file 0000891618-03-001533.txt   942825
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22570 | Film No.: 03626411
SIC: 2833 Medicinal Chemicals & Botanical Products